US Stock MarketDetailed Quotes

LRMR Larimar Therapeutics

Watchlist

6.130
+0.050+0.82%

Close Nov 21 16:00 ET

6.130
0.0000.00%

Post 16:41 ET

391.13MMarket Cap-5330P/E (TTM)

Larimar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Larimar Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Larimar Therapeutics Earnings Reports

Larimar Therapeutics | 10-Q: Q3 2024 Earnings Report

Oct 30 17:07 ET

Larimar Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 14:44 ET

Larimar Therapeutics | 10-Q: Q1 2024 Earnings Report

May 9 16:22 ET

Larimar Therapeutics | 10-K: FY2023 Annual Report

Mar 14 16:30 ET

Analyst Rating

Updated: Nov 21, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall